Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
119.4 USD | -0.12% | +1.08% | +6.43% |
May. 06 | Oppenheimer Adjusts Ensign Group Price Target to $135 From $130, Maintains Outperform Rating | MT |
May. 02 | Ensign Group Seeks Acquisition Opportunities | CI |
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The firm trades with high earnings multiples: 24.2 times its 2024 earnings per share.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.43% | 6.8B | B- | ||
-18.84% | 16.76B | B+ | ||
+3.60% | 12.65B | B | ||
+3.98% | 11.86B | B+ | ||
+4.28% | 10.28B | B+ | ||
+28.75% | 8.67B | B | ||
-6.94% | 7.6B | A- | ||
+8.59% | 6.52B | D | ||
+39.21% | 4.53B | - | ||
-3.49% | 4.39B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ENSG Stock
- Ratings The Ensign Group, Inc.